Kyoko Nohtomi

1.8k total citations
35 papers, 1.6k citations indexed

About

Kyoko Nohtomi is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Virology. According to data from OpenAlex, Kyoko Nohtomi has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Virology. Recurrent topics in Kyoko Nohtomi's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (8 papers) and Diabetes Treatment and Management (7 papers). Kyoko Nohtomi is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (8 papers) and Diabetes Treatment and Management (7 papers). Kyoko Nohtomi collaborates with scholars based in Japan, United States and Vietnam. Kyoko Nohtomi's co-authors include Tsutomu Hirano, Takuya Watanabe, Masaharu Nagashima, Michishige Terasaki, Yutaka Takebe, Masako Tomoyasu, Joo‐ri Kim‐Kaneyama, Ayumi Miyazaki, Hiroshi Demura and Kengo Sato and has published in prestigious journals such as Circulation, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Kyoko Nohtomi

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyoko Nohtomi Japan 23 595 571 287 270 267 35 1.6k
Mark A. Wallet United States 20 366 0.6× 137 0.2× 161 0.6× 210 0.8× 177 0.7× 34 1.5k
Howard Mostowski United States 21 548 0.9× 170 0.3× 357 1.2× 135 0.5× 158 0.6× 39 2.1k
Soumya Panigrahi United States 21 681 1.1× 42 0.1× 210 0.7× 106 0.4× 154 0.6× 37 1.7k
Peter Marschang Austria 19 234 0.4× 68 0.1× 244 0.9× 153 0.6× 116 0.4× 45 1.1k
James E. McLaren United Kingdom 22 468 0.8× 74 0.1× 83 0.3× 330 1.2× 155 0.6× 43 2.1k
Irina N. Baranova United States 18 566 1.0× 110 0.2× 21 0.1× 354 1.3× 68 0.3× 29 1.3k
Banishree Saha United States 24 1.0k 1.7× 210 0.4× 27 0.1× 134 0.5× 106 0.4× 28 2.4k
Chuan‐Chu Chou United Kingdom 19 519 0.9× 23 0.0× 165 0.6× 92 0.3× 155 0.6× 22 1.4k
Jian Peng China 19 388 0.7× 124 0.2× 86 0.3× 157 0.6× 136 0.5× 35 1.0k
G. Villegas United States 20 539 0.9× 48 0.1× 46 0.2× 97 0.4× 181 0.7× 34 1.3k

Countries citing papers authored by Kyoko Nohtomi

Since Specialization
Citations

This map shows the geographic impact of Kyoko Nohtomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Nohtomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Nohtomi more than expected).

Fields of papers citing papers by Kyoko Nohtomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoko Nohtomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Nohtomi. The network helps show where Kyoko Nohtomi may publish in the future.

Co-authorship network of co-authors of Kyoko Nohtomi

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoko Nohtomi. A scholar is included among the top collaborators of Kyoko Nohtomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoko Nohtomi. Kyoko Nohtomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sato, Kengo, Takuya Watanabe, Kyoko Nohtomi, et al.. (2014). A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis. Peptides. 54. 19–26. 127 indexed citations
2.
Sato, Kengo, Remina Shirai, Rena Watanabe, et al.. (2014). Vasoprotective Effects of Urocortin 1 against Atherosclerosis In Vitro and In Vivo. PLoS ONE. 9(12). e110866–e110866. 22 indexed citations
3.
Terasaki, Michishige, Masaharu Nagashima, Kyoko Nohtomi, et al.. (2013). Preventive Effect of Dipeptidyl Peptidase-4 Inhibitor on Atherosclerosis Is Mainly Attributable to Incretin's Actions in Nondiabetic and Diabetic Apolipoprotein E-Null Mice. PLoS ONE. 8(8). e70933–e70933. 64 indexed citations
4.
Terasaki, Michishige, Masaharu Nagashima, Takuya Watanabe, et al.. (2012). Effects of PKF275-055, a dipeptidyl peptidase–4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E–null mice. Metabolism. 61(7). 974–977. 56 indexed citations
5.
Nagashima, Masaharu, Takuya Watanabe, Michishige Terasaki, et al.. (2011). Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice. Diabetologia. 54(10). 2649–2659. 209 indexed citations
6.
Watanabe, Takuya, Masaharu Nagashima, Michishige Terasaki, et al.. (2010). Abstract 10278: Incretin-Based Treatments Prevent the Development of Atherosclerotic Lesions in Apolipoprotein E-Null Mice. Circulation. 122. 2 indexed citations
7.
Hirano, Tsutomu, Kyoko Nohtomi, Naohiko Nakanishi, et al.. (2010). Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients. Clinical Nephrology. 74(10). 282–287. 5 indexed citations
8.
Yabe, Daisuke, et al.. (2010). Intact Glucagon-like Peptide-1 Levels are not Decreased in Japanese Patients with Type 2 Diabetes. Endocrine Journal. 57(2). 119–126. 66 indexed citations
9.
Nohtomi, Kyoko, et al.. (2009). PTH(7-84) inhibits PTH(1-34)-induced 1,25-(OH)2D3 production in murine renal tubules. Biochemical and Biophysical Research Communications. 381(2). 283–287. 11 indexed citations
10.
Hirano, Tsutomu, et al.. (2009). Small dense LDL-cholesterol determined by a simple precipitation assay for screening familial combined hyperlipidemia. Atherosclerosis. 205(2). 603–607. 12 indexed citations
11.
Hirano, Tsutomu, et al.. (2008). A simple and precise method for measuring HDL-cholesterol subfractions by a single precipitation followed by homogenous HDL-cholesterol assay. Journal of Lipid Research. 49(5). 1130–1136. 45 indexed citations
12.
Iwata, Naoko, Yuko Sato, Kyoko Nohtomi, et al.. (2006). Distribution of PrP<sup>Sc</sup> in Cattle with Bovine Spongiform Encephalopathy Slaughtered at Abattoirs in Japan. Japanese Journal of Infectious Diseases. 59(2). 100–107. 44 indexed citations
13.
Li, Xiaojie, Shigeru Kusagawa, Xueshan Xia, et al.. (2005). Molecular Epidemiology of the Heterosexual HIV-1 Transmission in Kunming, Yunnan Province of China Suggests Origin from the Local IDU Epidemic. AIDS Research and Human Retroviruses. 21(11). 977–980. 35 indexed citations
14.
Yamakawa, Yoshio, K. Hagiwara, Kyoko Nohtomi, et al.. (2003). Atypical Proteinase K-Resistant Prion Protein (PrP<sup>res</sup>) Observed in an Apparently Healthy 23-Month-Old Holstein Steer. Japanese Journal of Infectious Diseases. 56(5-6). 221–222. 7 indexed citations
15.
Kato, Kayoko, Shigeru Kusagawa, Kazushi Motomura, et al.. (2001). Closely Related HIV-1 CRF01_AE Variant among Injecting Drug Users in Northern Vietnam: Evidence of HIV Spread across the Vietnam–China Border. AIDS Research and Human Retroviruses. 17(2). 113–123. 38 indexed citations
16.
Motomura, Kazushi, Shigeru Kusagawa, Kayoko Kato, et al.. (2000). Emergence of New Forms of Human Immunodeficiency Virus Type 1 Intersubtype Recombinants in Central Myanmar. AIDS Research and Human Retroviruses. 16(17). 1831–1843. 51 indexed citations
17.
Kato, Kayoko, Teiichiro Shiino, Shigeru Kusagawa, et al.. (1999). Genetic Similarity of HIV Type 1 Subtype E in a Recent Outbreak among Injecting Drug Users in Northern Vietnam to Strains in Guangxi Province of Southern China. AIDS Research and Human Retroviruses. 15(13). 1157–1168. 40 indexed citations
18.
Kusagawa, Shigeru, Hironori Sato, Seishiro Watanabe, et al.. (1998). Genetic and Serologic Characterization of HIV Type 1 Prevailing in Myanmar (Burma)*. AIDS Research and Human Retroviruses. 14(15). 1379–1385. 41 indexed citations
19.
Sato, Kanji, Kyoko Nohtomi, Hiroshi Demura, et al.. (1997). Saccharated ferric oxide (SFO)-induced osteomalacia: In vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules. Bone. 21(1). 57–64. 32 indexed citations
20.
Nohtomi, Kyoko, Kanji Sato, KAZUO SHIZUME, et al.. (1994). Stimulation of interleukin-4 of cell proliferation and mRNA expression of alkaline phosphatase and collagen type I in human osteoblast-like cells of trabecular bone. Bone and Mineral. 27(1). 69–79. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. Wallet Breakdown of academic impact, for papers by Howard Mostowski Breakdown of academic impact, for papers by Soumya Panigrahi Breakdown of academic impact, for papers by Peter Marschang Breakdown of academic impact, for papers by James E. McLaren Breakdown of academic impact, for papers by Irina N. Baranova Breakdown of academic impact, for papers by Banishree Saha Breakdown of academic impact, for papers by Chuan‐Chu Chou Breakdown of academic impact, for papers by Jian Peng Breakdown of academic impact, for papers by G. Villegas
Rankless by CCL
2026